Movantik Tablet, Film Coated
Product Images NDC 82625-8802

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Movantik (NDC 82625-8802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Valinor Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure of naloxegol oxalate, the active ingredient in MOVANTIK tablets. The diagram shows the molecular configuration including rings, hydroxyl groups, and the oxalate moiety.*

FDA Label Image

Figure 1 (Image 02)

A figure showing the ratio of geometric LS means with 90% confidence intervals for Cmax and AUC of Movantik when coadministered with various drugs. It compares effects of ketoconazole, diltiazem, quinidine, rifampin, and morphine, highlighting their influence as CYP3A4/Pgp inhibitors or inducers and on GI motility.*

FDA Label Image

Label-30s-12.5mg (Label 30s 12 5mg)

MOVANTIK (naloxegol) 12.5 mg film-coated tablets packaging label showing 30 tablets per container. Distributed by Valinor Pharma, LLC, Chicago, IL. The label includes storage instructions, barcode, and the statement that each tablet contains 14.2 mg naloxegol oxalate. Rx only.*

FDA Label Image

Label-30s-25mg (Label 30s 25mg)

MOVANTIK 25 mg film-coated tablets label showing naloxegol as the active ingredient. The label indicates a package of 30 tablets, distributed by Valinor Pharma, LLC. It includes dosage strength, NDC 82625-8802-1, storage conditions, and a barcode. The label notes the prescription status and directs dispensing the Medication Guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.